We have some exciting news to share! The Motley Fool UK has now become an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. We’ll be introducing a new name and brand over the coming weeks — we're very excited to share it with you and embark on this new chapter together!

2 dividend heroes with yields over 5% I’d buy now

These two stocks have high dividend yields and here’s why I think they can maintain them.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

High dividend yields aren’t always a good thing. We all want to chase the highest paying stock, but sometimes that isn’t the best course of action. That’s because struggling companies might boost the yield to attract investors and sometimes the yield is high simply because the share price has fallen due to the company struggling.

So dividend sustainability is key. Can the business afford its dividend or is a cut on the horizon? A company’s recent history will tell you whether the dividend is sustainable and if the stock is worth your money. Here are two I think are worth the price.

Pharmaceutical giant

GlaxoSmithKline (LSE: GSK) is my first pick, with its tempting dividend yield of 5.5%. It is currently priced at around 1,600p with a P/E ratio of around 20, not the best-looking P/E in the world, but I believe that even with its high price it can still reward investors. GlaxoSmithKline has steadily been paying dividend yields of around 5% to 6% for years now, reliably paying around 80p per share year after year. This reassures me that, despite market fluctuations, GSK can still bring in the money.

Such a high dividend could fluctuate, but CFO Iain MacKay has confirmed GSK’s commitment to the yield for this year. And the future? It has many products that are seeing great results with Ellipta respiratory sales climbing 20% and Nucala seeing 40% growth in Q1 this year. The company has three main areas of income that provide a safety net: consumer healthcare, vaccines and pharmaceuticals. Vaccines sales soared in Q1 due to the Shingrix shingles treatment. This vaccine accounted for £365m of sales, up from £110m in Q1 of 2018, which is more than a fifth of all vaccine revenue for the firm. Vaccine sales as a whole were up 23% in Q1. This huge amount of cash flow helps sustain a healthy dividend yield I believe is worth paying a high price for.

Reality show

ITV (LSE: ITV) is my next pick, with its mouthwatering yield of 7.6%. ITV shares are currently priced around 106p with a P/E ratio of 11.9. That ratio is lower than the UK average and the company has reasonable long-term debt levels of £981m with £424m operating cash flow in the last 12 months. This means an operating-cash-to-total-debt ratio of 40%, demonstrating how the debt is significantly covered.

ITV did well in Q1. Despite total national television viewers dropping 3%, its share of these views rose 24%. Registered ITV hub users have also risen by 29% this year, with statistics showing that there’s at least one ITV hub account in every UK household. These figures highlight how the company has an in-depth share of (and insight into) our TV habits. This is important as it plans to launch targeted ads on the hub accounts that should hopefully boost revenue this year, reassuring investors, despite the challenging TV advertising market.

Furthermore, the return of Love Island has also seen a huge boost in viewership, keeping ITV ahead during prime time TV hours. That upcoming launch of ITV hub tailored ads and an admittedly-modest 1% increase in revenues in Q1 shows the company has growth prospects ahead. With ITV stock prices being so low and a healthy dividend, I think that this undervalued investment is far too tempting to ignore. 

fional has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended ITV. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Frustrated young white male looking disconsolate while sat on his sofa holding a beer
Investing Articles

These FTSE shares have crashed hard. What now?

Investors who bought these FTSE shares have been hit with some painful losses so far, but has this just created…

Read more »

ISA Individual Savings Account
Investing Articles

How much is needed in a Stocks and Shares ISA to aim for an income of £9,874 a year?

Figures suggest that the average Civil Service pension is around £10,000. James Beard explains how a Stocks and Shares ISA…

Read more »

Investing Articles

Why Intel stock surged 125% in April

As AI shifts from training to inferencing, could the need for memory over speed make Intel the S&P 500 chip…

Read more »

Young brown woman delighted with what she sees on her screen
Investing Articles

Here’s 1 dirt cheap value stock paying BIG dividends

In my endless hunt for discounted value stocks, I found a business paying huge dividends with explosive 5x revenue growth…

Read more »

Array of piggy banks in saturated colours on high colour contrast background
Investing Articles

How to target £1,000 a month in retirement with a SIPP — starting today

Andrew Mackie explains how a SIPP strategy built on contributions, time, and returns can turn a £300,000 target into a…

Read more »

A couple celebrating moving in to a new home
Investing Articles

Starting with £10,000, how could someone aim to earn an annual second income of £12,548 from UK shares?

UK shares pay some of the world's most generous dividends. James Beard explains how domestic stocks could produce a five-figure…

Read more »

Investing Articles

Are Barclays shares a screaming buy at £3.99? 

Barclays shares have been on the slide lately, and Harvey Jones thinks they could fall even further next week, given…

Read more »

Senior Couple Walking With Pet Bulldog In Countryside
Investing Articles

How much do you need in an ISA for a £3,000 monthly passive income?

Investing in ISAs and SIPPs could eventually help you retire with a four-figure passive income every month. Royston Wild explains…

Read more »